世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

臨床試験サプライ&ロジスティクスの市場規模、シェア、動向分析レポート サービス別(物流・配布、保管・保持)、フェーズ別、地域別、セグメント別予測、2023~2030年


Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report By Service (Logistics & Distribution, Storage & Retention), By Phase, By Region, And Segment Forecasts, 2023 - 2030

臨床試験サプライ&ロジスティクス市場の成長・トレンド 世界の臨床試験サプライ&ロジスティクス市場は、2023年から2030年にかけて年平均成長率7.5%で拡大し、2030年には63億米ドルに達すると予測されます。... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年1月17日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

臨床試験サプライ&ロジスティクス市場の成長・トレンド

世界の臨床試験サプライ&ロジスティクス市場は、2023年から2030年にかけて年平均成長率7.5%で拡大し、2030年には63億米ドルに達すると予測されます。臨床試験サプライ&ロジスティクス市場における先端技術やイノベーションの台頭、厳格な規制の実施、COVID-19パンデミックなどの疾病の流行による臨床試験需要の高まりが背景にあります。

当初、COVID-19のパンデミックは、サプライチェーンの混乱や、ウイルスの拡散を防ぐための政府による民間航空会社の削減などにより、市場にマイナスの影響を及ぼしました。しかし、この病気を予防するためのCOVID-19ワクチンに対する需要の高まりにより、市場はすぐに回復し、大きく成長し始めました。例えば、WHOによると、2022年8月2日現在、臨床開発段階にあるワクチンは169種類、前臨床段階にあるワクチンは198種類となっています。

臨床試験用品プロバイダーによるサプライチェーンマネジメントソフトウェアへの投資が活発化している。臨床試験の複雑化や市場関係者間の競争激化が、サプライチェーン管理に新技術を採用する要因となっています。業界各社による新技術の採用が進んでいることから、在庫管理、サプライチェーン計画、補助的なサプライチェーン管理のためのソフトウェアに対するニーズが高まると予想されます。

臨床試験サプライ&ロジスティクス市場レポートハイライト

- サービス分野では、2022年に物流・流通が25.3%のシェアを獲得し、市場を独占した。これは、COVID- 19のパンデミックによる臨床試験の増加によるものです。

- フェーズ別では、フェーズIIIセグメントが2022年に43.4%のシェアを獲得し、市場を支配した

- 治療分野別では、心血管疾患が予測期間中に最も速いCAGR 8.0%を占めました。これは、市場に新規性と革新性をもたらすために、市場関係者による投資件数が増加したことに起因する

- アジア太平洋地域は、予測期間中に8.1%という最も速い成長率を記録すると予測されています。これは、採用コストが低いこと、多様で大規模な患者プールへのアクセスが可能であること、臨床試験に適した政策がとられていることによります。



ページTOPに戻る


目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Phase
1.1.3 End-User
1.1.4 Therapeutic Use
1.1.5 Regional Scope
1.1.6 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Clinical Trial Supply & Logistics Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Technological advancements in supply chain
3.1.1.2 Increasing R&D investment by pharmaceutical and biopharmaceutical firms
3.1.1.3 Expansion of clinical trial sites
3.1.2 Market Restraint Analysis
3.1.2.1 Stringent regulation pertaining to logistics
3.1.2.2 Counterfeiting of drugs
3.1.3 SWOT Analysis by PESTEL
3.1.4 Industry Analysis - Porter’s
3.1.5 Clinical Trial Supply & Logistics Market: Impact of COVID - 19
3.1.5.1 IMPACT OF COVID - 19
3.1.5.2 SUPPLY CHAIN
3.1.5.3 CHANGING MARKET TRENDS
Chapter 4 Clinical Trial Supply & Logistics Market: Segment Analysis, By Service, 2018 - 2030 (USD Million)
4.1 Definitions and Scope
4.2 Clinical Trial Supply & Logistics Market by Service: Segment Dashboard
4.3 Clinical Trial Supply & Logistics: Market Share Analysis, 2022 & 2030
4.3.1 logistics & Distribution
4.3.1.1 Logistics & Distribution Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.2 Storage & Retention
4.3.2.1 Storage & Retention Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.3 Packaging, Labeling, And Blinding
4.3.3.1 Packaging, Labellling, And Blinding Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.4 Manufacturing
4.3.4.1 Manufacturing Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.5 Comparator Sourcing
4.3.5.1 Comparator Sourcing Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.6 Other Services (Solutions, Ancillary Supply)
4.3.6.1 Other Services (Solutions, Ancillary Supply) Market Estimates And Forecast, 2018 - 2030 (In Million)
Chapter 5 Clinical Trial Supply & Logistics Market: Segment Analysis, By Phase, 2018 - 2030 (USD Million)
5.1 Definitions And Scope
5.2 Clinical Trial Supply & Logistics Market By Phase: Segment Dashboard
5.3 Clinical Trial Supply & Logistics: Market Share Analysis, 2022 & 2030
5.4 Clinical Trial Supply & Logistics Market By Phase
5.4.1 Phase I
5.4.1.1 Phase I Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.2 Phase Ii
5.4.2.1 Phase Ii Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.3 Phase Iii
5.4.3.1 Phase Iii Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.4 Phase Iv
5.4.4.1 Phase Iv Market Estimates And Forecast, 2018 - 2030 (In Million)
Chapter 6 Clinical Trial Supply & Logistics Market: Segment Analysis, By End-User, 2018 - 2030 (USD Million)
6.1 Definitions And Scope
6.2 Clinical Trial Supply & Logistics Market By End - User: Segment Dashboard
6.3 Clinical Trial Supply & Logistics: End-User Market Share Analysis, 2022 & 2030
6.4 Clinical Trial Supply & Logistics Market By End - User
6.4.1 Pharmaceutical
6.4.1.1 Pharmaceutical Market Estimates And Forecast, 2018 - 2030 (In Million)
6.4.2 Biologicals
6.4.2.1 Biologicals Market Estimates And Forecast, 2018 - 2030 (In Million)
6.4.3 Medical Devices
6.4.3.1 Medical Device Market Estimates And Forecast, 2018 - 2030 (In Million)
Chapter 7 Clinical Trial Supply & Logistics Market: Segment Analysis, By Therapeutic Areas, 2018 - 2030 (USD Million)
7.1 Definitions And Scope
7.2 Clinical Trial Supply & Logistics Market By Therapeutic Areas: Segment Dashboard
7.3 Clinical Trial Supply & Logistics: Therapeutic Areas Market Share Analysis, 2022 & 2030
7.4 Clinical Trial Supply & Logistics Market By Therapeutic Areas
7.4.1 Oncology
7.4.1.1 Oncology Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.2 Central Nervous System (Cns) Disorders
7.4.2.1 Cns Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.3 Cardiovascular Diseases
7.4.3.1 Cardiovascular Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.4 Respiratory Diseases
7.4.4.1 Respiratory Diseases Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.5 Others
7.4.5.1 Others Market Estimates And Forecast, 2018 - 2030 (In Million)
Chapter 8 Clinical Trials Supply & Logistics Market: Regional Estimates And Trend Analysis, By Service, Phase, End - User, & Therapeutic Area
8.1 North America
8.1.1 Swot Analysis:
8.1.1.1 North America Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.1.2 U.S.
8.1.2.1 Key Country Dynamics
8.1.2.2 Competitive Scenario
8.1.2.3 Regulatory Framework
8.1.2.4 U.S. Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.1.3 Canada
8.1.3.1 Key Country Dynamics
8.1.3.2 Competitive Scenario
8.1.3.3 Regulatory Framework
8.1.3.4 Canada Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2 Europe
8.2.1 Swot Analysis:
8.2.1.1 Europe Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.2 U.K.
8.2.2.1 Key Country Dynamics
8.2.2.2 Competitive Scenario
8.2.2.3 Regulatory Framework
8.2.2.4 Uk Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.3 France
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Regulatory Framework
8.2.3.4 France Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.4 Germany
8.2.4.1 Key Country Dynamics
8.2.4.2 Competitive Scenario
8.2.4.3 Regulatory Framework
8.2.4.4 Germany Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.5 Italy
8.2.5.1 Key Country Dynamics
8.2.5.2 Competitive Scenario
8.2.5.3 Regulatory Framework
8.2.5.4 Italy Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.6 Spain
8.2.6.1 Key Country Dynamics
8.2.6.2 Competitive Scenario
8.2.6.3 Regulatory Framework
8.2.6.4 Spain Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3 Asia Pacific
8.3.1 Swot Analysis:
8.3.1.1 Asia Pacific Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.1 India
8.3.1.1 Key Country Dynamics
8.3.1.2 Competitive Scenario
8.3.1.1 Regulatory Framework
8.3.1.2 India Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.2 Japan
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.1 Regulatory Framework
8.3.2.2 Japan Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.3 China
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.1 Regulatory Framework
8.3.3.2 China Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.4 Australia
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 Regulatory Framework
8.3.4.4 Australia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.5 South Korea
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Regulatory Framework
8.3.5.4 South Korea Vessel Sealing Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4 Latin America
8.4.1 Swot Analysis:
8.4.1.1 Latin America Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2 Brazil
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Regulatory Framework
8.4.2.4 Brazil Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3 Mexico
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Regulatory Framework
8.4.3.4 Mexico Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4 Argentina
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 Regulatory Framework
8.4.4.4 Argentina Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.5 Colombia
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Regulatory Framework
8.4.5.4 Colombia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.6 Chile
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Regulatory Framework
8.4.6.4 Chile Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5 Mea
8.5.1 Swot Analysis:
8.5.1.1 Mea Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2 South Africa
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Regulatory Framework
8.5.2.4 South Africa Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3 Saudi Arabia
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Regulatory Framework
8.5.3.4 Saudi Arabia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4 UAE
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Regulatory Framework
8.5.4.4 Uae Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5 Iran
8.5.5.1 Key Country Dynamics
8.5.5.2 Competitive Scenario
8.5.5.3 Regulatory Framework
8.5.5.4 Iran Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6 Israel
8.5.6.1 Key Country Dynamics
8.5.6.2 Competitive Scenario
8.5.6.3 Regulatory Framework
8.5.6.4 Israel Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Market Share
9.1.1 Company market share analysis (2022)
Chapter 10 Competitive Landscape
10.1 Participants’ Overview
10.2 Financial Performance
10.3 Strategy Initiatives
10.3.1 Acquisition
10.3.2 Collaboration/ Partnerships
10.3.3 Expansion
10.3.4 Product Launch
10.3.5 Others

 

ページTOPに戻る


 

Summary

Clinical Trials Supply & Logistics Market Growth & Trends

The global clinical trials supply & logistics market is expected to reach USD 6.3 billion by 2030, expanding at a CAGR of 7.5% from 2023 to 2030. The rise in advanced technology and innovations in the clinical trial supply & logistics market, implementation of stringent regulations, and the rising demand for clinical trials due to the increasing prevalence of diseases such as the COVID-19 pandemic.

Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus. However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.

There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management. The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.

Clinical Trials Supply & Logistics Market Report Highlights

• In service segment, logistics & distribution dominated the market in 2022 with a share of 25.3%. This is due to the rise in clinical trials due to COVID- 19 pandemic

• Based on phase, phase III segment dominated the market with a market share of 43.4% in 2022

• Based on therapeutic area, cardiovascular diseases accounted for the fastest CAGR of 8.0% during the forecast period. This is due to the rise in the number of investments by market players for bringing novel and innovation to the market

• Asia Pacific is anticipated to register the fastest growth rate of 8.1% during the forecast period. This is due to low recruitment cost, region has access to a large and diversified patient pool, and favorable policies that make the region desirable for clinical trials



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Phase
1.1.3 End-User
1.1.4 Therapeutic Use
1.1.5 Regional Scope
1.1.6 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Clinical Trial Supply & Logistics Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Technological advancements in supply chain
3.1.1.2 Increasing R&D investment by pharmaceutical and biopharmaceutical firms
3.1.1.3 Expansion of clinical trial sites
3.1.2 Market Restraint Analysis
3.1.2.1 Stringent regulation pertaining to logistics
3.1.2.2 Counterfeiting of drugs
3.1.3 SWOT Analysis by PESTEL
3.1.4 Industry Analysis - Porter’s
3.1.5 Clinical Trial Supply & Logistics Market: Impact of COVID - 19
3.1.5.1 IMPACT OF COVID - 19
3.1.5.2 SUPPLY CHAIN
3.1.5.3 CHANGING MARKET TRENDS
Chapter 4 Clinical Trial Supply & Logistics Market: Segment Analysis, By Service, 2018 - 2030 (USD Million)
4.1 Definitions and Scope
4.2 Clinical Trial Supply & Logistics Market by Service: Segment Dashboard
4.3 Clinical Trial Supply & Logistics: Market Share Analysis, 2022 & 2030
4.3.1 logistics & Distribution
4.3.1.1 Logistics & Distribution Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.2 Storage & Retention
4.3.2.1 Storage & Retention Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.3 Packaging, Labeling, And Blinding
4.3.3.1 Packaging, Labellling, And Blinding Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.4 Manufacturing
4.3.4.1 Manufacturing Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.5 Comparator Sourcing
4.3.5.1 Comparator Sourcing Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.6 Other Services (Solutions, Ancillary Supply)
4.3.6.1 Other Services (Solutions, Ancillary Supply) Market Estimates And Forecast, 2018 - 2030 (In Million)
Chapter 5 Clinical Trial Supply & Logistics Market: Segment Analysis, By Phase, 2018 - 2030 (USD Million)
5.1 Definitions And Scope
5.2 Clinical Trial Supply & Logistics Market By Phase: Segment Dashboard
5.3 Clinical Trial Supply & Logistics: Market Share Analysis, 2022 & 2030
5.4 Clinical Trial Supply & Logistics Market By Phase
5.4.1 Phase I
5.4.1.1 Phase I Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.2 Phase Ii
5.4.2.1 Phase Ii Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.3 Phase Iii
5.4.3.1 Phase Iii Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.4 Phase Iv
5.4.4.1 Phase Iv Market Estimates And Forecast, 2018 - 2030 (In Million)
Chapter 6 Clinical Trial Supply & Logistics Market: Segment Analysis, By End-User, 2018 - 2030 (USD Million)
6.1 Definitions And Scope
6.2 Clinical Trial Supply & Logistics Market By End - User: Segment Dashboard
6.3 Clinical Trial Supply & Logistics: End-User Market Share Analysis, 2022 & 2030
6.4 Clinical Trial Supply & Logistics Market By End - User
6.4.1 Pharmaceutical
6.4.1.1 Pharmaceutical Market Estimates And Forecast, 2018 - 2030 (In Million)
6.4.2 Biologicals
6.4.2.1 Biologicals Market Estimates And Forecast, 2018 - 2030 (In Million)
6.4.3 Medical Devices
6.4.3.1 Medical Device Market Estimates And Forecast, 2018 - 2030 (In Million)
Chapter 7 Clinical Trial Supply & Logistics Market: Segment Analysis, By Therapeutic Areas, 2018 - 2030 (USD Million)
7.1 Definitions And Scope
7.2 Clinical Trial Supply & Logistics Market By Therapeutic Areas: Segment Dashboard
7.3 Clinical Trial Supply & Logistics: Therapeutic Areas Market Share Analysis, 2022 & 2030
7.4 Clinical Trial Supply & Logistics Market By Therapeutic Areas
7.4.1 Oncology
7.4.1.1 Oncology Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.2 Central Nervous System (Cns) Disorders
7.4.2.1 Cns Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.3 Cardiovascular Diseases
7.4.3.1 Cardiovascular Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.4 Respiratory Diseases
7.4.4.1 Respiratory Diseases Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.5 Others
7.4.5.1 Others Market Estimates And Forecast, 2018 - 2030 (In Million)
Chapter 8 Clinical Trials Supply & Logistics Market: Regional Estimates And Trend Analysis, By Service, Phase, End - User, & Therapeutic Area
8.1 North America
8.1.1 Swot Analysis:
8.1.1.1 North America Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.1.2 U.S.
8.1.2.1 Key Country Dynamics
8.1.2.2 Competitive Scenario
8.1.2.3 Regulatory Framework
8.1.2.4 U.S. Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.1.3 Canada
8.1.3.1 Key Country Dynamics
8.1.3.2 Competitive Scenario
8.1.3.3 Regulatory Framework
8.1.3.4 Canada Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2 Europe
8.2.1 Swot Analysis:
8.2.1.1 Europe Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.2 U.K.
8.2.2.1 Key Country Dynamics
8.2.2.2 Competitive Scenario
8.2.2.3 Regulatory Framework
8.2.2.4 Uk Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.3 France
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Regulatory Framework
8.2.3.4 France Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.4 Germany
8.2.4.1 Key Country Dynamics
8.2.4.2 Competitive Scenario
8.2.4.3 Regulatory Framework
8.2.4.4 Germany Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.5 Italy
8.2.5.1 Key Country Dynamics
8.2.5.2 Competitive Scenario
8.2.5.3 Regulatory Framework
8.2.5.4 Italy Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.6 Spain
8.2.6.1 Key Country Dynamics
8.2.6.2 Competitive Scenario
8.2.6.3 Regulatory Framework
8.2.6.4 Spain Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3 Asia Pacific
8.3.1 Swot Analysis:
8.3.1.1 Asia Pacific Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.1 India
8.3.1.1 Key Country Dynamics
8.3.1.2 Competitive Scenario
8.3.1.1 Regulatory Framework
8.3.1.2 India Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.2 Japan
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.1 Regulatory Framework
8.3.2.2 Japan Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.3 China
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.1 Regulatory Framework
8.3.3.2 China Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.4 Australia
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 Regulatory Framework
8.3.4.4 Australia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.5 South Korea
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Regulatory Framework
8.3.5.4 South Korea Vessel Sealing Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4 Latin America
8.4.1 Swot Analysis:
8.4.1.1 Latin America Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2 Brazil
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Regulatory Framework
8.4.2.4 Brazil Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3 Mexico
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Regulatory Framework
8.4.3.4 Mexico Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4 Argentina
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 Regulatory Framework
8.4.4.4 Argentina Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.5 Colombia
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Regulatory Framework
8.4.5.4 Colombia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.6 Chile
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Regulatory Framework
8.4.6.4 Chile Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5 Mea
8.5.1 Swot Analysis:
8.5.1.1 Mea Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2 South Africa
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Regulatory Framework
8.5.2.4 South Africa Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3 Saudi Arabia
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Regulatory Framework
8.5.3.4 Saudi Arabia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4 UAE
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Regulatory Framework
8.5.4.4 Uae Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5 Iran
8.5.5.1 Key Country Dynamics
8.5.5.2 Competitive Scenario
8.5.5.3 Regulatory Framework
8.5.5.4 Iran Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6 Israel
8.5.6.1 Key Country Dynamics
8.5.6.2 Competitive Scenario
8.5.6.3 Regulatory Framework
8.5.6.4 Israel Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Market Share
9.1.1 Company market share analysis (2022)
Chapter 10 Competitive Landscape
10.1 Participants’ Overview
10.2 Financial Performance
10.3 Strategy Initiatives
10.3.1 Acquisition
10.3.2 Collaboration/ Partnerships
10.3.3 Expansion
10.3.4 Product Launch
10.3.5 Others

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る